AACR logo

More articles from Article

A β-lactamase with reduced immunogenicity for the targeted delivery of chemotherapeutics using antibody-directed enzyme prodrug therapy
Fiona A. Harding, Amy D. Liu, Marcia Stickler, O. Jennifer Razo, Regina Chin, Nargol Faravashi, Wendy Viola, Tom Graycar, V. Pete Yeung, Wolfgang Aehle, Daan Meijer, Stephanie Wong, M. Harunur Rashid, Ana M. Valdes, Volker Schellenberger

Molecular Cancer Therapeutics Nov 2005, 4 (11) 1791-1800; DOI: 10.1158/1535-7163.MCT-05-0189
Human single-domain neutralizing intrabodies directed against Etk kinase: a novel approach to impair cellular transformation
Keren Paz, Laura A. Brennan, Michelle Iacolina, Jacqueline Doody, Yaron R. Hadari, Zhenping Zhu

Molecular Cancer Therapeutics Nov 2005, 4 (11) 1801-1809; DOI: 10.1158/1535-7163.MCT-05-0174
Biological and molecular properties of a new α_vβ₃/α_vβ₅ integrin antagonist
Laura Belvisi, Teresa Riccioni, Marcella Marcellini, Loredana Vesci, Ilaria Chiarucci, Daniela Efrati, Donatella Potenza, Carlo Scolastico, Leonardo Manzoni, Katia Lombardo, M. Antonietta Stasi, Augusto Orlandi, Alessandro Ciucci, Beatrice Nico, Domenico Ribatti, Giuseppe Giannini, Marco Presta, Paolo Carminati, Claudio Pisano

Molecular Cancer Therapeutics Nov 2005, 4 (11) 1670-1680; DOI: 10.1158/1535-7163.MCT-05-0120
Gene therapy with E2F-1 up-regulates the protein kinase PKR and inhibits growth of leiomyosarcoma in vivo
Stephan A. Vorburger, Nophadol Hetrakul, Weiya Xia, Marcia Wilson-Heiner, Nadeem Mirza, Raphael E. Pollock, Barry Feig, Stephen G. Swisher, Kelly K. Hunt

Molecular Cancer Therapeutics Nov 2005, 4 (11) 1710-1716; DOI: 10.1158/1535-7163.MCT-05-0036
Angiogenesis and tumor growth inhibition by a matrix metalloproteinase inhibitor targeting radiation-induced invasion
Alexandre Kaliski, Laurence Maggiorella, Keith A. Cengel, Denis Mathe, Valerie Rouffiac, Paule Opolon, Nathalie Lassau, Jean Bourhis, Eric Deutsch

Molecular Cancer Therapeutics Nov 2005, 4 (11) 1717-1728; DOI: 10.1158/1535-7163.MCT-05-0179
Determination of the importance of the stereochemistry of psorospermin in topoisomerase II–induced alkylation of DNA and in vitro and in vivo biological activity
Ingrid M. Fellows, Michael Schwaebe, Thomas S. Dexheimer, Hariprasad Vankayalapati, Mary Gleason-Guzman, Jeffrey P. Whitten, Laurence H. Hurley

Molecular Cancer Therapeutics Nov 2005, 4 (11) 1729-1739; DOI: 10.1158/1535-7163.MCT-05-0183
Targeting integrin-linked kinase inhibits Akt signaling pathways and decreases tumor progression of human glioblastoma
Dimpy Koul, Ruijun Shen, Sherry Bergh, Yiling Lu, John F. de Groot, Ta Jen Liu, Gordon B. Mills, W.K. Alfred Yung

Molecular Cancer Therapeutics Nov 2005, 4 (11) 1681-1688; DOI: 10.1158/1535-7163.MCT-05-0258
The methyltransferase inhibitor 5-aza-2-deoxycytidine induces apoptosis via induction of 15-lipoxygenase-1 in colorectal cancer cells
Linda C. Hsi, Xiaopei Xi, Yuanqing Wu, Scott M. Lippman

Molecular Cancer Therapeutics Nov 2005, 4 (11) 1740-1746; DOI: 10.1158/1535-7163.MCT-05-0218
A novel antisense oligonucleotide inhibiting several antiapoptotic Bcl-2 family members induces apoptosis and enhances chemosensitivity in androgen-independent human prostate cancer PC3 cells
Kazuki Yamanaka, Palma Rocchi, Hideaki Miyake, Ladan Fazli, Bob Vessella, Uwe Zangemeister-Wittke, Martin E. Gleave

Molecular Cancer Therapeutics Nov 2005, 4 (11) 1689-1698; DOI: 10.1158/1535-7163.MCT-05-0064
Caspase-dependent apoptosis induction by guggulsterone, a constituent of Ayurvedic medicinal plant Commiphora mukul, in PC-3 human prostate cancer cells is mediated by Bax and Bak
Shivendra V. Singh, Yan Zeng, Dong Xiao, Victor G. Vogel, Joel B. Nelson, Rajiv Dhir, Yamini B. Tripathi

Molecular Cancer Therapeutics Nov 2005, 4 (11) 1747-1754; DOI: 10.1158/1535-7163.MCT-05-0223

Main menu

User menu

Search

More articles from Article

Pages

Articles

Info for

About MCT